345 related articles for article (PubMed ID: 17412659)
1. The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis.
Morabito N; Russo GT; Gaudio A; Lasco A; Catalano A; Morini E; Franchina F; Maisano D; La Rosa M; Plota M; Crifò A; Meo A; Frisina N
Bone; 2007 Jun; 40(6):1588-94. PubMed ID: 17412659
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.
Pietrapertosa AC; Minenna G; Colella SM; Santeramo TM; Renni R; D'Amore M
Panminerva Med; 2009 Mar; 51(1):17-23. PubMed ID: 19352306
[TBL] [Abstract][Full Text] [Related]
3. Markers of bone metabolism in eugonadal female patients with beta-thalassemia major.
Angelopoulos NG; Goula A; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Konstandelou E; Tolis G
Pediatr Hematol Oncol; 2007; 24(7):481-91. PubMed ID: 17786784
[TBL] [Abstract][Full Text] [Related]
4. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
García-Valdecasas-Campelo E; González-Reimers E; Santolaria-Fernández F; De la Vega-Prieto MJ; Milena-Abril A; Sánchez-Pérez MJ; Martínez-Riera A; Gómez-Rodríguez Mde L
Alcohol Alcohol; 2006; 41(3):261-6. PubMed ID: 16476762
[TBL] [Abstract][Full Text] [Related]
5. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle.
Morabito N; Gaudio A; Lasco A; Atteritano M; Pizzoleo MA; Cincotta M; La Rosa M; Guarino R; Meo A; Frisina N
J Bone Miner Res; 2004 May; 19(5):722-7. PubMed ID: 15068494
[TBL] [Abstract][Full Text] [Related]
7. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
8. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
Perifanis V; Vyzantiadis T; Tziomalos K; Vakalopoulou S; Garipidou V; Athanassiou-Metaxa M; Harsoulis F
Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
[TBL] [Abstract][Full Text] [Related]
9. Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease.
Monegal A; Navasa M; Peris P; Alvarez L; Pons F; Rodés J; Guañabens N
Liver Int; 2007 May; 27(4):492-7. PubMed ID: 17403189
[TBL] [Abstract][Full Text] [Related]
10. Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects.
Mangiafico RA; Malaponte G; Pennisi P; Li Volti G; Trovato G; Mangiafico M; Bevelacqua Y; Mazza F; Fiore CE
J Intern Med; 2007 Jun; 261(6):587-96. PubMed ID: 17547714
[TBL] [Abstract][Full Text] [Related]
11. Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism.
Baek KH; Oh KW; Lee WY; Tae HJ; Rhee EJ; Han JH; Cha BY; Kim YJ; Lee KW; Son HY; Kang SK; Kim CC; Kang MI
Bone; 2006 Dec; 39(6):1352-60. PubMed ID: 16905375
[TBL] [Abstract][Full Text] [Related]
12. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis.
Hofbauer LC; Schoppet M; Christ M; Teichmann J; Lange U
Rheumatology (Oxford); 2006 Oct; 45(10):1218-22. PubMed ID: 16574701
[TBL] [Abstract][Full Text] [Related]
14. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
Kim JG; Kim JH; Lee DO; Kim H; Kim JY; Suh CS; Kim SH; Choi YM
Menopause; 2008; 15(2):357-62. PubMed ID: 17925661
[TBL] [Abstract][Full Text] [Related]
15. Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis.
Papadaki HA; Tsatsanis C; Christoforidou A; Malliaraki N; Psyllaki M; Pontikoglou C; Miliaki M; Margioris AN; Eliopoulos GD
J Bone Miner Metab; 2004; 22(6):577-87. PubMed ID: 15490268
[TBL] [Abstract][Full Text] [Related]
16. Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.
Ricci P; Tauchmanova L; Risitano AM; Carella C; Mazziotti G; Lombardi G; Colao A; Rotoli B; Selleri C
Transplantation; 2006 Dec; 82(11):1449-56. PubMed ID: 17164716
[TBL] [Abstract][Full Text] [Related]
17. Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major.
Eren E; Yilmaz N
Int J Clin Pract; 2005 Jan; 59(1):46-51. PubMed ID: 15707464
[TBL] [Abstract][Full Text] [Related]
18. Correlation of serum cytokine levels with axial bone mineral density.
Sahin G; Ozturk C; Bagis S; Cimen OB; Erdogan C
Singapore Med J; 2002 Nov; 43(11):576-8. PubMed ID: 12680527
[TBL] [Abstract][Full Text] [Related]
19. Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation.
Lee WY; Baek KH; Rhee EJ; Tae HJ; Oh KW; Kang MI; Lee KW; Kim SW; Kim CC; Oh ES
Bone Marrow Transplant; 2004 Jul; 34(1):89-94. PubMed ID: 15170175
[TBL] [Abstract][Full Text] [Related]
20. Bone metabolism and mineral density in patients with beta-thalassemia major.
Dundar U; Kupesiz A; Ozdem S; Gilgil E; Tuncer T; Yesilipek A; Gultekin M
Saudi Med J; 2007 Sep; 28(9):1425-9. PubMed ID: 17768474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
